Market Cap:
24h Vol:
Stocklytics Platform
Instrument logo  ATRI

Atrion Corp

58 / 100
Key Stats
Prev. Close$340.17
Next Earnings DateMar 1, 2024
Dividend Yield %2.51%
Market Cap$616.50M
PE Ratio29.00
Day Range341.45
52 Week Range274.98
P/B Ratio2.57
Operating M. %9.70%
Earnings Growth %-39.13%
EBITDA Margin %23.30%
ROE %8.76%
Gross Profit$64.24M
Total Debt$4.50M
P/S Ratio3.5x
Enterprise to EBITDA15.90
Profit Margin12.64%
Debt/Equity Ratio0.02%
Payout Ratio117.94%
Industry average yield3.04%
Last Dividend pay dateDec 15, 2023
Dividend per share$8.65
Dividend yield forecast0.03%

Stock Analysis


Summarizing what the indicators are suggesting.

Strong Buy
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Strong Sell

Stock Performance

US Healthcare Sectorarrow_drop_up0.65%
US Marketarrow_drop_up0.51%
ATRI / Market
ATRI exceeded the US Market which returned 0.51% over the last twenty four hours.
ATRI / Healthcare Sector
ATRI exceeded the US Healthcare sector which returned 0.65% over the last twenty four hours.

Atrion Corp (ATRI) Statistics

ATRI (Atrion Corp) is a company engaged in the development, manufacturing, and marketing of products for medical applications. They offer a wide range of innovative solutions to healthcare professionals worldwide. With a focus on quality and precision, ATRI has established itself as a leader in the industry. Let's take a look at some key statistics for ATRI stock. The valuation metrics for ATRI indicate a company that is performing well in the market. With a high valuation multiple, ATRI is seen as a valuable investment. The fundamentals of ATRI are strong, with a solid balance sheet and consistent revenue growth. ATRI has been able to outperform its sector in terms of stock performance. This demonstrates the company's ability to weather market fluctuations and deliver strong returns to investors. ATRI has a healthy revenue per share, indicating that they are able to generate significant income for each share of stock. The Enterprise to EBITDA ratio for ATRI is also favorable, showing that the company is able to generate strong earnings from its operations. ATRI has a respectable profit margin, indicating that they are able to generate a profit from their revenue. This is an important indicator of financial health and efficiency. ATRI has a manageable level of total debt, which is reassuring for investors. This suggests that the company is able to meet its financial obligations and has a solid financial position overall. ATRI has a healthy gross profit, which demonstrates their ability to generate revenue after accounting for the costs of production. This is a positive indicator of efficiency and profitability. The CEO of ATRI plays a crucial role in the company's success. The CEO is responsible for setting the strategic direction of the company, overseeing its operations, and ensuring that it delivers value to its shareholders. Overall, ATRI is a strong company with a solid financial position, strong fundamentals, and a dedicated CEO.

ATRI (Atrion Corp) is a leading company in the medical industry, specializing in the development, manufacturing, and marketing of innovative products. With a focus on quality and precision, ATRI has become a trusted name in healthcare. When it comes to stock statistics, ATRI stands out. The valuation metrics for ATRI indicate that the market recognizes the value of the company. Investors have confidence in ATRI's ability to perform well in the market. Looking at the fundamentals, ATRI shows strength. The balance sheet is stable, with consistent revenue growth over time. This stability extends to the stock performance as well. ATRI has consistently outperformed its sector, a testament to the company's resilience in the face of market fluctuations. A key indicator of ATRI's performance is the revenue per share. This metric shows that ATRI is able to generate significant income for each share of stock. Furthermore, the Enterprise to EBITDA ratio is favorable, indicating strong earnings from operations. ATRI's profit margin is healthy, demonstrating their ability to generate a profit from their revenue. This positive financial performance is further supported by a manageable total debt level. ATRI has been able to maintain a solid financial position, meeting its financial obligations efficiently. Another positive sign is the healthy gross profit, indicating efficient production and profitability. The CEO of ATRI is a key figure in the company's success. Leading the strategic direction and overseeing operations, the CEO plays a crucial role in delivering value to shareholders. ATRI is an industry leader with strong fundamentals, solid financials, and a dedicated CEO at the helm.

add Atrion Corp to watchlist

Keep an eye on Atrion Corp

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

How has Atrion Corp (ATRI) stock's performance compared to its sector and the market over the past year?

Over the past year, Atrion Corp (ATRI) has experienced a price change of -48.69%. Compared to the Healthcare sector, which saw a change of 35.66%, Atrion Corp has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.15%, it has fallen short of the market average. This comparison highlights Atrion Corp's performance relative to both its sector and the overall market over the last year.

What is the PE ratio of Atrion Corp (ATRI) stock?

The PE (Price to Earnings) ratio of Atrion Corp (ATRI) is currently 29. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

What is the EPS of Atrion Corp (ATRI) stock?

The Earnings Per Share (EPS) for Atrion Corp (ATRI), calculated on a diluted basis, is $12.08. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

What is the operating margin of Atrion Corp (ATRI) stock?

The operating margin for Atrion Corp (ATRI) is 9.7%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

What is the EBITDA of Atrion Corp (ATRI) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Atrion Corp (ATRI) is $40.85M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

How much debt does Atrion Corp (ATRI) have?

Atrion Corp (ATRI) has a total debt of $4.5M. The net debt, which accounts for cash and cash equivalents against the total debt, is $3.84M.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.